CM Life Sciences Inc (CMLF)
NASDAQ
The current CMLF market cap is 300.25M. The company's latest EPS is USD -6.7906 and P/E is -5.75.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | ||
Total Revenue | 49.04M | 53.3M | 57.42M | 62.42M | 70.51M |
Operating Income | -51.62M | -34.35M | -37.75M | -13.66M | -10.58M |
Net Income | -46.72M | -43.32M | -24.74M | -20.24M | -29.17M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 212.2M | 234.69M | 202.57M |
Operating Income | -206k | -446.15M | -457.51M | -182.3M |
Net Income | -192k | -245.39M | -548.98M | -175.77M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | ||
Total Assets | 476.39M | 417.29M | 418.76M | 394.53M | 389.1M |
Total Liabilities | 180.28M | 163.03M | 190.74M | 187.31M | 195.06M |
Total Equity | 296.11M | 254.26M | 228.02M | 207.22M | 194.04M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 444.14M | 554.09M | 490.94M | 418.76M |
Total Liabilities | 15.59M | 165.99M | 237.24M | 190.74M |
Total Equity | 5M | 388.1M | 253.71M | 228.02M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | ||
Operating | -109.06M | -150.29M | -180.15M | -16.41M | -20.92M |
Investing | -11.73M | -38.86M | -43.73M | 843k | -21.86M |
Financing | 140.05M | 139.14M | 186.24M | -438k | -829k |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -386k | -190.43M | -319.16M | -180.15M |
Investing | -442.75M | -20.79M | -141.33M | -43.73M |
Financing | 444.23M | 493.73M | 197.32M | 186.24M |
Market Cap | 300.25M |
Price to Earnings Ratio | -5.75 |
Price to Sales Ratio | 4.99 |
Price to Cash Ratio | 10.14 |
Price to Book Ratio | 4.43 |
Dividend Yield | - |
Shares Outstanding | 25.88M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.15 (1.27%) |
Company Name | CM Life Sciences Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.genedx.com |
Industry | health services (8000) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.